Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Usefulness of a Treat and Extend Regimen Using Ranibizumab for Neovascular Age-Related Macular Degeneration.

NCT02321839 is registered in ClinicalTrials.gov with Nagoya City University as lead sponsor.

NCT NCT02321839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02321839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Usefulness of a Treat and Extend Regimen Using Ranibizumab for Neovascular Age-Related Macular Degeneration.
Lead sponsor
Nagoya City University
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2014
Completion date
March 31, 2019
Enrollment
78 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

neovascular age-related macular degeneration